Healthcare News Secrets
Novo CEO pressed by Senate to chop price ranges of obesity, diabetes medications CEO Lars Fruergaard Jørgensen told lawmakers the organization would consider new talks with insurers in regards to the list selling prices of Wegovy and copyright whenever they pledge to help keep the medicines on their formularies.Never miss tomorrow's healthcare bus